The six-monthly anti-HIV jab, which prevents HIV through sex, is now stocked for free at 360 government clinics in six of South Africa's provinces.

The provinces are Gauteng, KwaZulu-Natal, the Eastern Cape, Mpumalanga, North West and the Western Cape, according to the health department's list of clinics. The Northern Cape, Limpopo and the Free State will get jabs in 2027, when cheaper generic versions of

South African Health Minister Aaron Motsoaledi announced that the country will launch its rollout of the twice-yearly HIV prevention injection, lenacapavir (LEN), on June 5. LEN represents one of the biggest advances in HIV prevention to date. When taken by individuals who are HIV-negative, it is nearly foolproof in preventing sexual transmission of the virus.

New medicines alone, however, cannot halt an

Pharmaceutical company Gilead Sciences has come under mounting pressure after refusing to sell its breakthrough HIV prevention drug, lenacapavir, directly to Médecins Sans Frontières (MSF), despite repeated requests.

In an open letter, the group renewed its repeated requests to California-based Gilead to sell the drug, saying the

A group of public health physicians is calling for fresh negotiations between Harare and Washington to continue after the collapse of a proposed $367 million bilateral health agreement.

The proposed deal would reportedly have bolstered the country's priority health sectors, including HIV/AIDS treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

Over the past four decades, HIV's ability to mutate and hide in viral reservoirs has made finding a cure difficult. Discussions on paediatric HIV cure research have revealed how early treatment can lead to ART-free remission, though not full viral eradication, as researchers stressed the ethical challenges of involving

An African-led research initiative working to develop an HIV vaccine, under the aegis of The BRILLIANT Consortium, has launched the BRILLIANT 011 trial at the Desmond Tutu Health Foundation in Cape Town. The trial is being conducted by the South African Medical Research Council (SAMRC) and aims to tackle the specific strains of the virus circulating in Southern Africa.

With the first participant already enrolled,

The World Health Organization (WHO) has called on African governments to strengthen healthcare systems in order to protect the hard-won gains against HIV amid a rapidly changing global funding landscape that threatens to slow progress.

In a message commemorating the 2025 World AIDS Day, WHO's Regional Director for Africa, Dr. Mohamed Janabi, said global pullbacks in HIV financing are putting pressure on

Abrupt funding cuts and deteriorating human rights conditions have disrupted HIV prevention and treatment services across dozens of countries, UNAIDS has warned.

In a report to mark World AIDS Day, the UN agency said international assistance has sharply declined, with projections showing external health funding could fall by

Over 100 low-income countries are expected to have access to a new HIV prevention drug within two years, potentially bringing the world closer to an end to the HIV/AIDS epidemic. The drug, called Lenacapavir and administered by injection, is due to be rolled out as early as the end of this year, and was slashed to about $40 per person

Scientists, doctors, activists, and people living with HIV didn't mince their words. With U.S. donor funding shrinking, the future looks grim unless urgent steps are taken. The numbers are frightening - between now and 2028, the country could face up to 295,000 new HIV infections and as many as 60,000 AIDS-related deaths if nothing changes, writes allAfrica's Sethi Ncube after attending the 12th South African AIDS Conference in Gauteng.